Showing results (1-10 of 17) with videos related to
Sort By:
Pageof 2
Oncotargets and Therapy|December 26, 2018
Pathological complete response induced by neoadjuvant treatment using BRAF and MEK inhibitors in a patient with unresectable BRAF V600E-mutant malignant melanoma of the gallbladderZhou Yu, Elisa Quiroz, Yulei Shen, et al.BMJ Case Reports|October 31, 2013
Aggressive plasmablastic multiple myeloma in a 42-year-old: is inflammatory bowel disease or infliximab treatment to be blamed?Siddhartha Yadav, Ramesh Kumar, Ishmael A Jaiyesimi, et al.BMJ Case Reports|October 12, 2013
Peripheral T-cell lymphoma in a patient with Crohn's diseaseSrilakshmi Sudha Kollepara, Mohammad Muhsin Chisti, Seerin Viviane Shatavi, et al.Journal of Blood Medicine|September 5, 2020
Current Perspectives on Diagnostic Assays and Anti-PF4 Antibodies for the Diagnosis of Heparin-Induced ThrombocytopeniaKamal K Sahu, Vishal Jindal, Joseph Anderson, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 6, 2023
Therapy for Stage IV Non-Small-Cell Lung Cancer Without Driver Alterations: ASCO Living Guideline, Version 2023.1Navneet Singh, Ishmael A Jaiyesimi, Nofisat Ismaila, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 6, 2023
Therapy for Stage IV Non-Small-Cell Lung Cancer With Driver Alterations: ASCO Living Guideline, Version 2023.1Navneet Singh, Ishmael A Jaiyesimi, Nofisat Ismaila, et al.Therapeutic Advances in Infectious Disease|August 26, 2021
Fungal infections in hematopoietic stem-cell transplant patients: a review of epidemiology, diagnosis, and managementMandeep Singh Rahi, Vishal Jindal, Prachi Pednekar, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 22, 2023
Therapy for Stage IV Non-Small-Cell Lung Cancer Without Driver Alterations: ASCO Living Guideline, Version 2022.3Ishmael A Jaiyesimi, Dwight H Owen, Nofisat Ismaila, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 21, 2023
Therapy for Stage IV Non-Small-Cell Lung Cancer With Driver Alterations: ASCO Living Guideline, Version 2022.3Ishmael A Jaiyesimi, Dwight H Owen, Nofisat Ismaila, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 11, 2023
Therapy for Stage IV Non-Small-Cell Lung Cancer With Driver Alterations: ASCO Living Guideline, Version 2023.2Dwight H Owen, Navneet Singh, Nofisat Ismaila, et al.Pageof 2